We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Research Shows Three Years of Generic Approvals Yield $53.3 Billion in Savings
FDA Research Shows Three Years of Generic Approvals Yield $53.3 Billion in Savings
New generic drug approvals in 2018, 2019 and 2020 yielded $53.3 billion in savings, according to a new FDA report that analyzed results from 2,400 approved new generic drug applications.
